Evidence map›Paper›PMID 23014776›Full record

ReviewChemical Society reviews2013

BODIPY dyes in photodynamic therapy.

Anyanee Kamkaew, Siang Hui Lim, Hong Boon Lee, Lik Voon Kiew, Lip Yong Chung, Kevin Burgess

Abstract readReview
In one paragraph

Review in Chemical Society reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 305 papers.

0numbers the graph read from it
0cells of the map it votes in
305citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

305 citing papers in PubMed.

  1. Shedding light on the cancer cell death mechanism in photodynamic therapy.Apoptosis : an international journal on programmed cell death · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Smart molecules : open access · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Advances in BODIPY Derivatives for Antibacterial Phototherapy.Angewandte Chemie (International ed. in English) · 2026
    Review
  12. Article
  13. Article
  14. Real-Time Monitoring of Excited-State Ring-Puckering Process in BODIPY Molecule Using Ultrafast Spectroscopy.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

245 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anyanee KamkaewDepartment of Chemistry, Box 30012, Texas A & M University, College Station, TX 77841-3012, USA.
Siang Hui Lim
Hong Boon Lee
Lik Voon Kiew
Lip Yong Chung
Kevin Burgess

Funding

Development of an Optimized System for Non-covalent Delivery of Proteins into CelR01GM087981 · NIGMS · TEXAS A&M UNIVERSITY · PI BURGESS, KEVIN · 2009 to 2012
$1.3M
NIGMS NIH HHS GM087981NIGMS NIH HHS R01 GM087981
6 · The paper itself

Abstract

BODIPY dyes tend to be highly fluorescent, but their emissions can be attenuated by adding substituents with appropriate oxidation potentials. Substituents like these have electrons to feed into photoexcited BODIPYs, quenching their fluorescence, thereby generating relatively long-lived triplet states. Singlet oxygen is formed when these triplet states interact with (3)O(2). In tissues, this causes cell damage in regions that are illuminated, and this is the basis of photodynamic therapy (PDT). The PDT agents that are currently approved for clinical use do not feature BODIPYs, but there are many reasons to believe that this situation will change. This review summarizes the attributes of BODIPY dyes for PDT, and in some related areas.

Indexed as

PhotochemotherapyBoron CompoundsFluorescent DyesPhotosensitizing Agents4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsFluorescent DyesPhotosensitizing Agents

Identifiers

PMID23014776
PMCPMC3514588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.